• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mol Cell Proteomics . Variation of Site-Specific Glycosylation Profiles of Recombinant Influenza Glycoproteins

tetano

Editor, Senior Moderator
Mol Cell Proteomics


. 2024 Aug 9:100827.
doi: 10.1016/j.mcpro.2024.100827. Online ahead of print. Variation of Site-Specific Glycosylation Profiles of Recombinant Influenza Glycoproteins

Zachary C Goecker[SUP] 1 [/SUP], Meghan C Burke[SUP] 2 [/SUP], Concepcion A Remoroza[SUP] 2 [/SUP], Yi Liu[SUP] 2 [/SUP], Yuri A Mirokhin[SUP] 2 [/SUP], Sergey L Sheetlin[SUP] 2 [/SUP], Dmitrii V Tchekhovskoi[SUP] 2 [/SUP], Xiaoyu Yang[SUP] 2 [/SUP], Stephen E Stein[SUP] 2 [/SUP]



Affiliations
Free article Abstract

This work presents a detailed determination of site-specific N-glycan distributions of the recombinant influenza glycoproteins hemagglutinin and neuraminidase. Variation in glycosylation among recombinant glycoproteins is not predictable and can depend on details of the biomanufacturing process as well as details of protein structure. In this study, recombinant influenza proteins were analyzed from eight strains of four different suppliers. These include five hemagglutinin and three neuraminidase proteins, each produced from a HEK293 cell line. Digestion was conducted using a series of complex multi-enzymatic methods designed to isolate glycopeptides containing single N-glycosylated sites. Site-specific glycosylation profiles of intact glycopeptides were produced using a recently developed method and comparisons were made using spectral similarity scores. Variation in glycan abundances and distribution was most pronounced between different strains of virus (similarity score = 383 out of 999), whereas digestion replicates and injection replicates showed relatively little variation (similarity score = 957). Notably, glycan distributions for homologous regions of influenza glycoprotein variants showed low variability. Due to the multiple possible sources of variation and inherent analytical difficulties in site-specific glycan determinations, variations were individually examined for multiple factors, including differences in supplier, production batch, protease digestion and replicate measurement. After comparing all glycosylation distributions, four distinguishable classes could be identified for the majority of sites. Finally, attempts to identify glycosylation distributions on adjacent potential N-glycosylated sites of one HA variant were made. Only the second site (NnST) was found to be occupied using two rarely used proteases in proteomics, subtilisin and esperase, both of which did selectively cleave these adjacent sites.


 
Back
Top Bottom